Type of information: Company acquisition
Acquired company: mySugr (Austria)
Acquiring company: Roche (Switzerland)
- • On June 30, 2017, Roche and mySugr announced that the two partners have signed an agreement under which Roche acquired all shares of the mobile diabetes platform mySugr. This platform will become an integral part of Roche’s new patient-centered digital health services platform in diabetes care. The acquisition allows Roche to expand its leading position in the area of diabetes management.
- Founded in 2012, mySugr specializes in all-around care for people with diabetes. Its apps and services combine diabetes coaching, therapy management, unlimited test-strips, automated data tracking, and seamless integration with a growing number of medical devices to ease the daily burden of living with diabetes. The company has offices in San Diego, California, and Vienna, Austria, with 47 employees across both locations. The mySugr App is available in 52 countries and 13 languages.
- As a focal point for Roche`s integrated diabetes management strategy, mySugr is foreseen to remain a separate legal entity with an open platform for all diabetes devices and services. Users will continue to have the ability to automatically upload blood glucose data from their preferred device into the mySugr logbook app as well as the facilitated data sharing with healthcare professionals and caregivers.